| Due Diligence for Asset Managers |
|---|
|
You have viewed 10 of the 10 daily limit Subscribe for $29/month to gain full access |
|
⚲
|
| Keyboard |
| Nuvectis Pharma Inc | |
|---|---|
| Ticker | NVCT |
| CIK # | 0001875558 |
| CUSIP | 67080T108 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 1 Bridge Plaza, Suite 275, Fort Lee, NJ 07024 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Nuvectis Pharma Inc | 2022-08-10 | 15.9 M | Exemption: 506(b) · Duration: One year or less · Commission: $1,355,294 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001875558] | 10-K | |
| [0001875558] | 10-Q | |
| [0001875558] | 3 | |
| [0001875558] | 4 | |
| [0001875558] | 8-K | |
| [0001875558] | D | |
| [0001875558] | SC 13D | |
| [0001875558] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Pontifax Management 4 GP 2015 Ltd | Nuvectis Pharma Inc | [2024-02-06] | 5.3 |
| Peters Thomas Phineas | Nuvectis Pharma Inc | [2023-04-03] | 6.4 |
| Shemesh Shay | Nuvectis Pharma Inc | [2023-02-13] | 8.2 |
| Poradosu Enrique | Nuvectis Pharma Inc | [2023-02-13] | 8.3 |
| Bentsur Ron | Nuvectis Pharma Inc | [2022-03-28] | 21.46 |
| Mosseri Marlio Charles | Nuvectis Pharma Inc | [2022-02-15] | 0.95 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bentsur Ron
Common Stock
|
2026-01-06 | Grant | 150,000 | $0.00 | |
|
Poradosu Enrique
Common Stock
|
2026-01-06 | Grant | 150,000 | $0.00 | |
|
Shemesh Shay
Common Stock
|
2026-01-06 | Grant | 150,000 | $0.00 | |
|
Carson Michael J
Common Stock
|
2026-01-06 | Grant | 61,200 | $0.00 | |
|
Bentsur Ron
Common Stock
|
2025-11-05 | Buy | 5,000 | $5.72 | 28,600 |
|
Sanchez Juan
Common Stock
|
2025-11-05 | Buy | 13,000 | $5.79 | 75,270 |
|
Kaplan Matthew L
Common Stock
|
2025-11-05 | Buy | 11,000 | $5.84 | 64,240 |
|
Mosseri Marlio Charles
Common Stock
|
2025-10-27 | Buy | 72,836 | $6.28 | 457,410 |
|
Mosseri Marlio Charles
Common Stock
|
2025-10-24 | Buy | 35,034 | $6.15 | 215,459 |
|
Mosseri Marlio Charles
Common Stock
|
2025-10-23 | Buy | 46,900 | $6.06 | 284,214 |
|
Sanchez Juan
Common Stock
|
2025-09-22 | Grant | 30,000 | $0.00 | |
|
Mosseri Marlio Charles
Common Stock
|
2025-06-20 | Buy | 5,603 | $7.99 | 44,768 |
|
Mosseri Marlio Charles
Common Stock
|
2025-06-18 | Buy | 28,043 | $8.05 | 225,746 |
|
Mosseri Marlio Charles
Common Stock
|
2025-06-17 | Buy | 5,399 | $8.11 | 43,786 |
|
Hoberman Kenneth
Common Stock
|
2025-06-12 | Grant | 30,000 | $0.00 | |
|
Kaplan Matthew L
Common Stock
|
2025-06-12 | Grant | 30,000 | $0.00 | |
|
Oliviero James F III
Common Stock
|
2025-06-12 | Grant | 30,000 | $0.00 | |
|
Mosseri Marlio Charles
Common Stock
|
2025-05-12 | Buy | 21,167 | $8.11 | 171,664 |
|
Common Stock
|
2025-05-09 | Buy | 5,395 | $8.98 | 48,447 |
|
Common Stock
|
2025-05-09 | Buy | 9,817 | $8.90 | 87,371 |
| showing 20 of 183 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 63 | 4,538,240 |
| 2025-12-31 | 50 | 4,408,726 |
| 2025-09-30 | 54 | 3,797,853 |
| 2025-06-30 | 49 | 3,368,540 |
| 2025-03-31 | 35 | 2,250,640 |
| 2024-12-31 | 32 | 1,320,778 |
| 2024-09-30 | 32 | 1,049,581 |
| 2024-06-30 | 42 | 1,219,844 |
| 2024-03-31 | 41 | 1,649,528 |
| 2023-12-31 | 37 | 1,541,136 |
| 2023-09-30 | 34 | 1,277,304 |
| 2023-06-30 | 38 | 1,252,927 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Baldwin Wealth Partners LLC/MA | [2026-06-30] | SOLE | 382,015 | 382,015 |
| Forbes J M & Co LLP | [2026-06-30] | SOLE | 59,000 | 59,000 |
| Gamma Investing LLC | [2026-06-30] | DFND | 489 | 489 |
| IFP Advisors LLC | [2026-06-30] | SOLE | 90 | 90 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 21 |
| True Wealth Design LLC | [2026-06-30] | SOLE | 0 | 4 | Prev | Page 1 | Next |